2006 Press/Media Releases:

CYTOCHROMA INITIATES PHASE II CLINICAL TRIAL FOR PSORIASIS
November 13, 2006

MEDIA STATEMENT: CYTOCHROMA MOVES FORWARD DESPITE GENZYME LAWSUIT
August 22, 2006

CYTOCHROMA ACQUIRES PROVENTIV THERAPEUTICS TO COMMERCIALIZE NEW VITAMIN D PRODUCTS FOR CKD MARKET
June 29, 2006

CYTOCHROMA’S VITAMIN D ANALOG SHOWS PROMISING RESULTS IN MULTIPLE SCLEROSIS MODEL
June 07, 2006

CYTOCHROMA ANNOUNCES SIGNIFICANT RESULTS WITH CTA002, A VITAMIN D ANALOG AND ENZYME INHIBITOR, IN A PROSTATE CANCER MODEL
May 10, 2006

CTA002, A NOVEL VITAMIN D ANALOG, SHOWS SIGNIFICANT ANTI-TUMOR ACTIVITY IN HUMAN NEUROBLASTOMA
April 26, 2006

CYTOCHROMA GRANTED FDA APPROVAL TO COMMENCE PHASE II CLINICAL TRIAL FOR NOVEL TOPICAL TREATMENT OF PSORIASIS
February 20, 2006

< Archives >